EGFR and non-small cell lung carcinoma: Data from ADAURA are lacking but literature data report that protein 53 (p53) is the most frequently co-mutated gene in early-stage EGFR-mutant NSCLC [32,33], and it is also associated with a poor prognosis in this setting [34].